Tag archive for ‘Advaxis’
SmithOnStocks Mailbox, January 31 Edition: My Take on News Events Relating to Companies I Follow
Introduction A number of subscribers have suggested that I write more on recent news events that relate to companies that I follow. This note is in response to these requests giving my take on some recent news releases. I would appreciate your feedback on whether this is of any value to you. I am considering […]
Advaxis: A Look at the Dizzying Trading Activity over the Past Month (ADXS, No opinion, $9.70)
Introduction My approach to my website in the two years I have been publishing is to in-depth research on a limited number of emerging biotechnology companies. To date, I have seldom written on companies on which I have not done a comprehensive analysis. However, I have done work on numerous other companies and sometimes have […]
The BIO CEO Conference: Highlights from the Meeting and New Investment Perspectives (Subscribers Only)
Back From BIO CEO Conference I have returned from spending two days at the BIO CEO conference at the Waldorf Astoria in New York City. Through attending presentations or one on one meetings, I heard presentations from Advanced Cell Technology ACTC), Advaxis (ADXS), Agenus (AGEN), Alexion (ALXN) , Alkermes (ALKM), Aradigm (ARDM), Athersys (ATHX), Celator […]